Pharma might get what it wants from Medicaid after all

A thing that annoys the drug industry is a rule that requires companies to offer Medicaid the lowest possible price on a given product, a provision pharma says stands in the way of new payment ideas, like paying for drugs based on how well they work.

But that could be up for a change. As STAT’s Nicholas Florko reports, a planned change to that rule was buried in a list of upcoming potential regulations released by the White House. Details are scant, and no action is expected until next summer at the earliest, but it’s a welcome sign that the industry could soon find a sympathetic ear in Washington.

Read more.